Regenerative Medical Technology Group Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Regenerative Medical Technology Group Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
  • Regenerative Medical Technology Group Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.08M, a 2.29% decline year-over-year.
  • Regenerative Medical Technology Group Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$10.2M, a 68.1% decline year-over-year.
  • Regenerative Medical Technology Group Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$9.81M, a 78.2% decline from 2022.
  • Regenerative Medical Technology Group Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$5.51M, a 57.3% increase from 2021.
  • Regenerative Medical Technology Group Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.9M, a 119% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$9.81M -$4.31M -78.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-15
2022 -$5.51M +$7.38M +57.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 -$12.9M -$6.99M -119% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-14
2020 -$5.9M -$3.39M -135% Jan 1, 2020 Dec 31, 2020 10-K 2022-05-05
2019 -$2.51M -$452K -21.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-13
2018 -$2.06M -$1.68M -446% Jan 1, 2018 Dec 31, 2018 10-K 2020-12-09
2017 -$377K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.